Regent Pacific Group Limited (HKG:0575)
Hong Kong
· Delayed Price · Currency is HKD 1.010
-0.010 (-0.98%)
Jun 26, 2025, 3:56 PM HKT
Regent Pacific Group Revenue
In the year 2024, Regent Pacific Group had annual revenue of $719.00K USD with 147.08% growth. Regent Pacific Group had revenue of $676.00K in the half year ending December 31, 2024, with 569.31% growth.
Revenue
$719.00K
Revenue Growth
+147.08%
P/S Ratio
41.31
Revenue / Employee
$42.29K
Employees
17
Market Cap
230.72M HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 719.00K | 428.00K | 147.08% |
| Dec 31, 2023 | 291.00K | 177.00K | 155.26% |
| Dec 31, 2022 | 114.00K | -3.14M | -96.50% |
| Dec 31, 2021 | 3.25M | 1.58M | 94.85% |
| Dec 31, 2020 | 1.67M | 1.51M | 918.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| WuXi Biologics | 19.87B |
| Sino Biopharmaceutical | 30.72B |
| CSPC Pharmaceutical Group | 28.99B |
| Akeso | 2.26B |